April 11, 2015Open Access

Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Performance status and the mGPS are superior prognostic factors in advanced lung cancer. In combination, these improved survival prediction compared with either alone.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Simmons et al. (Sat,) studied this question.

synapsesocial.com/papers/69d9c0be387cf7069868556b https://doi.org/https://doi.org/10.1016/j.lungcan.2015.03.020

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status2004 · 14 citations
2Definition and classification of cancer cachexia: an international consensus2011 · 5,643 citations
3How Accurate are Physicians’ Clinical Predictions of Survival and the Available Prognostic Tools in Estimating Survival Times in Terminally Ill Cancer Patients? A Systematic Review2001 · 130 citations
4Prognostic factors among cancer patients with good performance status screened for phase I trials2007 · 55 citations
5Performance status assessment in cancer patients1990 · 364 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo